Baidu
map

药品信息速递

订阅

MedSci主页 / 所有栏目 / 药品信息速递

超过三分之一的美国HIV患者没有接受乙肝疫苗接种

2017-12-26 MedSci MedSci原创

HIV患者乙肝疫苗
关注

尽管有很高的感染风险，但美国超过三分之一的艾滋病患者没有接种乙肝疫苗。这些研究结果发表在《内科学年鉴》上。艾滋病毒感染者的乙肝病毒感染风险增加，建议接种疫苗。然而，艾滋病病毒感染者中与肝脏有关的死亡人数，其中以乙型肝炎为主，占与艾滋病无关的死亡人数的比例最大。2016年，世界卫生组织(WHO)决心在2030年前消除HBV感染作为公共卫生威胁。为了评估艾滋病毒患者乙肝疫苗接种的流行情况，并为世卫组织


尽管有很高的感染风险，但美国超过三分之一的艾滋病患者没有接种乙肝疫苗。这些研究结果发表在《内科学年鉴》上。

艾滋病毒感染者的乙肝病毒感染风险增加，建议接种疫苗。然而，艾滋病病毒感染者中与肝脏有关的死亡人数，其中以乙型肝炎为主，占与艾滋病无关的死亡人数的比例最大。2016年，世界卫生组织(WHO)决心在2030年前消除HBV感染作为公共卫生威胁。

为了评估艾滋病毒患者乙肝疫苗接种的流行情况，并为世卫组织初始化建立一个基准，美国疾病控制与预防中心(CDC)的研究人员对18089名接受艾滋病毒治疗的成年人进行了全国代表性抽样调查，这些人在2009年至2012年期间参与了医疗监控项目。他们发现超过三分之一的美国艾滋病病毒感染者没有接种过乙肝疫苗。此外，只有十分之一的患者在进行了1年的艾滋病毒治疗的过程中接种了疫苗。

研究人员认为，达到消除乙型肝炎的目标需要多方面的方法来增加艾滋病病毒感染者的接种率。应该特别注意在私人诊所和没有由瑞安·怀特(Ryan White)艾滋病项目资助的机构中接受护理的病人的疫苗接种。


此文系梅斯医学（MedSci)原创整理编译，转载需授权！

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2057826, encodeId=206b205e82663, content=<a href='/topic/show?id=95a4234396e' target=_blank style='color:#2F92EE;'>#乙肝疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23439, encryptionId=95a4234396e, topicName=乙肝疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Jun 06 07:39:00 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2003359, encodeId=8def200335961, content=<a href='/topic/show?id=5012890397' target=_blank style='color:#2F92EE;'>#HIV患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8903, encryptionId=5012890397, topicName=HIV患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b505306, createdName=医生2394, createdTime=Mon Jul 09 19:39:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257846, encodeId=c30a125e8465f, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Dec 28 01:39:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272654, encodeId=30342e265406, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Tue Dec 26 12:12:21 CST 2017, time=2017-12-26, status=1, ipAttribution=)]
    2018-06-06 一叶知秋

    #乙肝疫苗接种#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2057826, encodeId=206b205e82663, content=<a href='/topic/show?id=95a4234396e' target=_blank style='color:#2F92EE;'>#乙肝疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23439, encryptionId=95a4234396e, topicName=乙肝疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Jun 06 07:39:00 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2003359, encodeId=8def200335961, content=<a href='/topic/show?id=5012890397' target=_blank style='color:#2F92EE;'>#HIV患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8903, encryptionId=5012890397, topicName=HIV患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b505306, createdName=医生2394, createdTime=Mon Jul 09 19:39:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257846, encodeId=c30a125e8465f, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Dec 28 01:39:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272654, encodeId=30342e265406, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Tue Dec 26 12:12:21 CST 2017, time=2017-12-26, status=1, ipAttribution=)]
    2018-07-09 医生2394

    #HIV患者#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2057826, encodeId=206b205e82663, content=<a href='/topic/show?id=95a4234396e' target=_blank style='color:#2F92EE;'>#乙肝疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23439, encryptionId=95a4234396e, topicName=乙肝疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Jun 06 07:39:00 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2003359, encodeId=8def200335961, content=<a href='/topic/show?id=5012890397' target=_blank style='color:#2F92EE;'>#HIV患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8903, encryptionId=5012890397, topicName=HIV患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b505306, createdName=医生2394, createdTime=Mon Jul 09 19:39:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257846, encodeId=c30a125e8465f, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Dec 28 01:39:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272654, encodeId=30342e265406, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Tue Dec 26 12:12:21 CST 2017, time=2017-12-26, status=1, ipAttribution=)]
    2017-12-28 lishiwen

    #疫苗接种#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2057826, encodeId=206b205e82663, content=<a href='/topic/show?id=95a4234396e' target=_blank style='color:#2F92EE;'>#乙肝疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23439, encryptionId=95a4234396e, topicName=乙肝疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Jun 06 07:39:00 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2003359, encodeId=8def200335961, content=<a href='/topic/show?id=5012890397' target=_blank style='color:#2F92EE;'>#HIV患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8903, encryptionId=5012890397, topicName=HIV患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b505306, createdName=医生2394, createdTime=Mon Jul 09 19:39:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257846, encodeId=c30a125e8465f, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Dec 28 01:39:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272654, encodeId=30342e265406, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Tue Dec 26 12:12:21 CST 2017, time=2017-12-26, status=1, ipAttribution=)]
    2017-12-26 1e0e5a1fm42(暂无匿称)

    henhao

    0

Baidu
map
Baidu
map
Baidu
map